To gain further insight into the value of FoxP3+ Tregs infiltration as an effective biomarker, we investigated the association between FoxP3+ Tregs level and certain clinicopathological parameters in patients with CRC. This evidence concerns the gene FOXP3 and colorectal carcinoma.